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Based on imipenem resistance in an Acinetobacter genospecies 3 clinical isolate, we were able to identify, for
the first time in this genomic species, a plasmid-encoded blaOXA-58 gene that was 100% homologous to the same
gene in Acinetobacter baumannii.
Since 1986 members of the genus Acinetobacter are deter-
mined by DNA-DNA hybridization. Genospecies 1 (Acineto-
bacter calcoaceticus), 2 (A. baumannii), 3, and 13TU are ge-
netically closely related and are commonly known as the A.
calcoaceticus-A. baumannii complex. With the exception of
genospecies 1, the other members of this complex have been
involved in nosocomial infections and have the ability to
spread in hospitals (3, 9, 19, 23, 25, 26). Treatment of these
nosocomial infections is becoming a problem because increas-
ing resistance to antibiotics, especially in the case of A. bau-
mannii. In the last decade, carbapenem resistance in Acineto-
bacter spp. has been reported worldwide (3, 16, 23), mostly
associated with the synthesis of carbapenem-hydrolyzing -lac-
tamases, reduced outer membrane permeability and, occasion-
ally, modification of penicillin-binding proteins (7, 16, 22, 27).
The most prevalent carbapenemases in Acinetobacter spp. are
the carbapenem-hydrolyzing class D -lactamases, which are
divided into four phylogenetic subgroups: OXA-23, OXA-24,
and OXA-58 with all their variants and the OXA-51 family,
which is intrinsic to A. baumannii (16, 27).
OXA-58 confers reduced susceptibility to carbapenems, but
it produces high-level resistance to carbapenems when addi-
tional efflux mechanisms are expressed (12, 15). It was first
identified in France in 2003 and, at present, is found worldwide
in A. baumannii isolates (13, 16, 20, 21), as well as in A. junii
isolates from Romania and Australia (12, 14).
The clinical isolates Ac057 (Acinetobacter sp. strain G3) and
Ac058 (A. baumannii) were obtained from the same hospital in
November 2000 and were identified by amplified ribosomal
DNA restriction analysis (ARDRA) (6, 24). The epidemiolog-
ical difference was corroborated by pulsed-field gel electro-
phoresis (PFGE) with ApaI (Promega, Madrid, Spain) under
conditions described elsewhere (11).
Antimicrobial susceptibility analysis was performed by Etest
according to the manufacturer’s instructions (AB Biodisk,
Sölna, Sweden) and determined that both strains had an imi-
penem MIC of 32 g/ml (Table 1). The breakpoints for
imipenem were those proposed by the Clinical and Laboratory
Standards Institute (5).
PCR analysis with specific primers for all class D -lactamases
(Table 2) determined the presence of the blaOXA-58 gene in
both strains; A. baumannii strain Ac058 was also positive for
the blaOXA-51 gene. Additional primers were designed at the
beginning and end of the blaOXA-58 gene (Table 2) to amplify
the whole fragment. This gene presented 100% homology with
the blaOXA-58 gene from A. baumannii listed in GenBank.
Plasmid DNA identification was attempted by using genomic
mapping with I-CeuI (10) and by digestion with the S1 nuclease
(1). I-CeuI cuts a 26-bp site in the rrl gene (23S rRNA), shearing
the bacterial genome into an analyzable number of fragments
(10). The S1 nuclease transforms supercoiled plasmids into linear
molecules (1). Digested genomic DNA and plasmids were sepa-
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TABLE 1. MICs for the clinical isolates used in this study
Strain
MIC (g/ml)a
AMP PIP CEF FOX CAZ FEP SAM IMP MEM CIP GEN TOB AMK DOX AZM RIF PMB
Ac057 256 512 256 256 8 8 8 32 8 32 1 0.25 0.5 0.5 4 2 2
Ac058 256 512 256 256 256 64 64 32 8 64 16 64 256 16 128 2 1
Abbreviations: AMP, ampicillin; PIP, piperacillin; CEF, cephalothin; FOX, cefoxitin; CAZ, ceftazidime; FEP, cefepime; SAM, ampicillin-sulbactam; IMP, imipenem; MEM,
Meropenem; CIP, ciprofloxacin; GEN, gentamicin; TOB, tobramycin; AMK, amikacin; DOX, doxycycline; AZM, azithromycin; RIF, rifampin; PMB, polymyxin B.
2955


























brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by idUS. Depósito de Investigación Universidad de Sevilla
rated by PFGE (Fig. 1). Probes were marked with the PCR DIG
probe synthesis kit (Roche, Barcelona, Spain), and detection was
performed with anti-digoxigenin antibody conjugated to alkaline
phosphatase and the color substrates NBT/BCIP (Roche) accord-
ing to the manufacturer’s instructions. In Fig. 1a, the most intense
bands would represent fragments of genomic DNA, and the
faded bands represent plasmid DNA. Hybridization with probes
for the blaOXA-58 gene (Fig. 1c) and the 23S rRNA gene (Fig. 1b)
suggest that in both isolates the blaOXA-58 gene is present in a
plasmid. With the S1 nuclease (Fig. 2a), the highest band would
be the genomic DNA and the remaining bands would be linear
plasmids. Hybridization with the probe for the OXA-58 gene
(Fig. 2c) gives the same pattern as obtained with I-CeuI. The
hybridization signal with the probe for the 23S rRNA gene was
only observed in the undigested genomic DNA (Fig. 2b). Al-
though conjugation experiments did not show any plasmid trans-
fer between strains, Southern blot analysis suggests that the
blaOXA-58 gene could be present in a plasmid in both strains, and
the plasmid from A. baumannii is possibly different from the
plasmid in the Acinetobacter genospecies 3 isolate.
In order to determine the genetic structure surrounding of
the blaOXA-58 gene, DNA from both isolates was digested with
MspI “C*CGG” (Promega). The fragments obtained were au-
toligated overnight at 16°C using a T4 DNA ligase (Promega).
TABLE 2. Oligonucleotide sequences used in this study
Nucleotide Sequence (5–3) Size (bp) Use
OXA51-1 AACAAGCGCTATTTTTATTTCAG 641 Detection blaOXA-51 variants
OXA51-2 CCCATCCCCAACCACTTTT
OXA23-1 GATGTGTCATAGTATTCGTCGT 641 Detection blaOXA-23 variants
OXA23-2 TCACAACAACTAAAAGCACTGT
OXA24-1 ATGAAAAAATTTATACTTCCTATATTCAGC 825 Detection blaOXA-24 variants
OXA24-2 TTAAATGATTCCAAGATTTTCTAGC
OXA58-1 AGTATTGGGGCTTGTGCT 453 Detection blaOXA-58 variants
OXA58-2 AACTTCCGTGCCTATTTG Southern blot probea
OXA58-1TOT ATGAAATTATTAAAAATATTG 843 Total gene amplification
OXA58-2TOT TTATAAATAATGAAAAACACC Total gene amplification
OXA58-inv1 GAGCGCAGAGGGGAGAATCGTC Genetic surrounding
OXA58-inv2 CTCAGCACAAGCCCCAATACT Genetic surrounding
OXA58-inv3 AAGCCATGCAAGCATCTACA Genetic surrounding
OXA58-inv4 CATCTCTTTCACTTGTTGCTGAA Genetic surrounding
a Primers OXA58-1 and OXA58-2 were used for detecting the blaOXA-58 gene and also to generate the probe for Southern blot analysis.
FIG. 1. Plasmid identification by genomic mapping with I-CeuI. (a)
PFGE gel. (b) Hybridization with probe for the 23S rRNA gene. (c)
Hybridization with probe for the OXA-58. Lane 1, A. baumannii strain
Ac058; lane 2, Acinetobacter genospecies 3 strain Ac057.
FIG. 2. Plasmid identification by digestion with S1 nuclease. (a)
PFGE gel (b). Hybridization with probe for the 23S rRNA gene. (c)
Hybridization with probe for the OXA-58. Lane 1, A. baumannii strain
Ac058; lane 2. Acinetobacter genospecies 3 strain Ac057.
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The fragment of DNA containing the blaOXA-58 gene was used
as a template for a PCR with inverse primers designed from
the blaOXA-58 gene sequence (Table 2). All PCR fragments
were sequenced using a BigDye Terminator v3.1 cycle se-
quencing kit (Applied Biosystems, Warrington, United King-
dom) and analyzed in an automatic DNA sequencer (3100
Genetic Analyzer; Applied Biosystems).
Analysis of the genetic surrounding confirms that both plas-
mids are different (Fig. 3). In Ac057, the blaOXA-58 gene is
surrounded by two copies of the Insertion Sequence ISAba3;
the copy downstream has the same direction as the blaOXA-58
gene, and the upstream copy has the opposite direction (Fig.
3). This structure has already been described in A. baumannii
by Poirel et al. (17, 18).
The presence of the OXA-58 alone does not account for the
level of resistance to imipenem of these isolates (MIC of 32
g/ml). Further work is needed to determine whether addi-
tional efflux pumps or porin modifications are involved.
A. baumannii is certainly the most frequently isolated spe-
cies in hospitals and also the microorganism of greatest clinical
interest in this genus. However, Acinetobacter genospecies 3
and 13 are also nosocomial pathogens, and they should be
considered in hospital settings. Previous studies in Acineto-
bacter genospecies 3 have revealed the presence of AmpC (2),
IMP-4 (4), and blaVIM-2 (28). In addition to these previously
described enzymes, we report here, for the first time, the pres-
ence of the blaOXA-58 in this microorganism. The main reason
for the lack of interest on non-baumannii Acinetobacter isolates
is probably their susceptibility to antimicrobial agents (9).
However, as suggested by Horrevorts et al. (8), the clinical
significance of genospecies 3 can be underestimated because
the resistant strains can be erroneously classified as A. bau-
mannii.
Nucleotide sequence accession number. The GenBank ac-
cession number for the blaOXA-58 in Acinetobacter genospecies
3 is EU642594.
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